CEVEC NEWS

CYTIVA STRENGTHENS CELL LINE DEVELOPMENT WITH CEVEC ACQUISITION

  • Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies
  • 46 scientific experts based in Cologne, Germany, join the Cytiva team in the genomic medicine space
  • Cytiva customers will have immediate access to technologies that solve some of the greatest challenges in bringing gene therapies to patients

October 6, 2022

KEEP IN TOUCH

Subscribe to receive CEVEC’s latest Press Releases, Conference Information and Webinar Invitations according to our Privacy Policy.

© CEVEC Pharmaceuticals GmbH 2022